Feb 16, 2018 - Top Research Reports for Novo Nordisk, TJX Companies & Cigna
Feb 11, 2018 - Which of these giant drugmakers is the better stock to buy, now that they've been knocked down a few pegs?
Feb 06, 2018 - It's a tale of two cities for the diabetes specialist.
Feb 05, 2018 - Losses on Wall Street and falling bond yields weighed on global markets this week.
Feb 03, 2018 - Most obesity drugs haven't been huge successes. But these stocks just might be.
Feb 01, 2018 - Novo Nordisk (NYSE:NVO) Q4 2017 Earnings Conference Call February 01, 2018 07:00 AM ET Executives Lars Fruergaard Jørgensen - CEO Jesper Brandgaard - CFO Mads Krogsgaard Thomsen - CSO Lars Green - EVP
Feb 01, 2018 - While Allergan's (AGN) Q4 sales are likely to be driven by new as well as established products like Botox and international growth, generic competition for some key products will hurt sales.
Feb 01, 2018 - Novo Nordisk's (NVO) top-line growth was backed by growth in new-generation insulin, Victoza, Saxenda, and haemophilia products.
Jan 30, 2018 - Novo Nordisk (NVO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Jan 30, 2018 - Merck's (MRK) new products like Keytruda and Bridion are likely to drive sales in the fourth quarter. However, headwinds remain in the form of genericization of key drugs and increasing competition.